Anne S. De Groot MD

Anne S. De Groot MD

Company: EpiVax, Inc.

Job title: CEO/CSO


Discussing Tregitope Formulation Challenges & Solutions to Maximize Antigen-Specific Tolerance for Allergy, Transplant or Autoimmune Indications 12:00 pm

Developing validation assays to select Tregitopes for clinical use Assessing the pros and cons of different formulations and combinations of Tregitopes and Antigens to induce immune tolerance Identifying the optimal application for translating Tregitope to the clinicRead more

day: Day Two | Track B | Afternoon

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.